Shima DT - Search Results

1

An in vitro assay reveals a role for the diaphragm protein PV-1 in endothelial fenestra morphogenesis.

Ioannidou S, Deinhardt K, Miotla J, Bradley J, Cheung E, Samuelsson S, Ng YS, Shima DT. Ioannidou S, et al. Among authors: shima dt. Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):16770-5. doi: 10.1073/pnas.0603501103. Epub 2006 Oct 30. Proc Natl Acad Sci U S A. 2006. PMID: 17075074 Free PMC article.

2

RGS5 expression is a quantitative measure of pericyte coverage of blood vessels.

Mitchell TS, Bradley J, Robinson GS, Shima DT, Ng YS. Mitchell TS, et al. Among authors: shima dt. Angiogenesis. 2008;11(2):141-51. doi: 10.1007/s10456-007-9085-x. Epub 2007 Nov 25. Angiogenesis. 2008. PMID: 18038251

3

VEGF function in vascular pathogenesis.

Ng YS, Krilleke D, Shima DT. Ng YS, et al. Among authors: shima dt. Exp Cell Res. 2006 Mar 10;312(5):527-37. doi: 10.1016/j.yexcr.2005.11.008. Epub 2005 Dec 5. Exp Cell Res. 2006. PMID: 16330026 Review.

4

Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization.

Jo N, Mailhos C, Ju M, Cheung E, Bradley J, Nishijima K, Robinson GS, Adamis AP, Shima DT. Jo N, et al. Among authors: shima dt. Am J Pathol. 2006 Jun;168(6):2036-53. doi: 10.2353/ajpath.2006.050588. Am J Pathol. 2006. PMID: 16723717 Free PMC article.

5

Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice.

Zhong L, Bradley J, Schubert W, Ahmed E, Adamis AP, Shima DT, Robinson GS, Ng YS. Zhong L, et al. Among authors: shima dt. Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1212-8. doi: 10.1167/iovs.06-0757. Invest Ophthalmol Vis Sci. 2007. PMID: 17325165

6

A Na,K-ATPase-Fodrin-Actin Membrane Cytoskeleton Complex is Required for Endothelial Fenestra Biogenesis.

Ju M, Ioannidou S, Munro P, Rämö O, Vihinen H, Jokitalo E, Shima DT. Ju M, et al. Among authors: shima dt. Cells. 2020 Jun 3;9(6):1387. doi: 10.3390/cells9061387. Cells. 2020. PMID: 32503129 Free PMC article.

7

A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165.

Lee JH, Canny MD, De Erkenez A, Krilleke D, Ng YS, Shima DT, Pardi A, Jucker F. Lee JH, et al. Among authors: shima dt. Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):18902-7. doi: 10.1073/pnas.0509069102. Epub 2005 Dec 15. Proc Natl Acad Sci U S A. 2005. PMID: 16357200 Free PMC article.

8

Molecular mapping and functional characterization of the VEGF164 heparin-binding domain.

Krilleke D, DeErkenez A, Schubert W, Giri I, Robinson GS, Ng YS, Shima DT. Krilleke D, et al. Among authors: shima dt. J Biol Chem. 2007 Sep 21;282(38):28045-56. doi: 10.1074/jbc.M700319200. Epub 2007 Jul 10. J Biol Chem. 2007. PMID: 17626017 Free article.

9

Simultaneous but not prior inhibition of VEGF165 enhances the efficacy of photodynamic therapy in multiple models of ocular neovascularization.

Ju M, Mailhos C, Bradley J, Dowie T, Ganley M, Cook G, Calias P, Lange N, Adamis AP, Shima DT, Robinson GS. Ju M, et al. Among authors: shima dt. Invest Ophthalmol Vis Sci. 2008 Feb;49(2):662-70. doi: 10.1167/iovs.07-0195. Invest Ophthalmol Vis Sci. 2008. PMID: 18235012

10

Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.

Nishijima K, Ng YS, Zhong L, Bradley J, Schubert W, Jo N, Akita J, Samuelsson SJ, Robinson GS, Adamis AP, Shima DT. Nishijima K, et al. Among authors: shima dt. Am J Pathol. 2007 Jul;171(1):53-67. doi: 10.2353/ajpath.2007.061237. Am J Pathol. 2007. PMID: 17591953 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters